Trading Statement
LONDON--(BUSINESS WIRE)--Jan. 30, 2003--
30 January 2003 - Trading Update
Tate & Lyle issues the following routine trading update.
Group profit before tax in the third quarter of the year to 31 March
2003 has been in line with our expectations. Since the end of
September 2002 net debt, assisted by proceeds from the sale of
non-core assets, has continued to reduce.
In the US, Staley has substantially completed the negotiation of its
calendar 2003 sales contracts. Overall, we expect to maintain
sweetener margins at calendar 2002 levels. Higher margins are
anticipated on basic starch and food ingredient products but citric
acid selling prices continue to be affected by global oversupply.
In Europe, small pricing gains at Amylum in certain markets and
products (such as vital wheat gluten) have been offset by price
reductions elsewhere. Based on current raw material prices, margins in
calendar 2003 are expected to be similar to those achieved in calendar
2002.
For more information contact:
Mark Robinson, Head of Investor Relations
investorrelations@tateandlyle.com
Tel: 020 7626 6525
Chris Fox, Head of Group Corporate Relations (Press)
Tel: 020 7626 6525
About Tate & Lyle
Tate & Lyle is a world leader in carbohydrate ingredients. Our core
competence is to take basic carbohydrates - corn, wheat or sugar - and
add value to these raw materials through technology. As a result of
continuous innovation we offer an ever-wider product portfolio of
versatile and functional ingredients. These products include Cereal
Sweeteners, Starches, Sugars and Citric Acid. Our products have wide
applications in the food, beverage, pharmaceutical, cosmetic, paper,
packaging and building industries.
With headquarters in London, the Group has 8,500 employees and 50
plants in 24 countries. Sales in the year to 31 March 2002 totalled
£3.9bn. Tate & Lyle ordinary shares trade on the London Stock Exchange
under TATE.L. In the US, ADRs trade on the NASD OTC Bulletin Board
under TATYY (each ADR is equal to four ordinary shares). Additional
information can be found at the website www.tateandlyle.com.
Short Name: Tate & Lyle PLC
Category Code: TST
Sequence Number: 00001739
Time of Receipt (offset from UTC): 20030129T174833+0000
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.